Clinical implications and management of drug-drug interactions between antiretroviral agents and psychotropic medications
Authors:
- Meredith G. JerniganMJMeredith G. Jernigan
- Gretchen M. KippGKGretchen M. Kipp
- Ashley RatherARAshley Rather
- Matthew T. JenkinsMJMatthew T. Jenkins
- Allison M. ChungACAllison M. Chung
- 1 March 2013
- journal article
- Published by American Association of Psychiatric Pharmacists (AAPP) in Mental Health Clinician
- Vol. 2 (9) , 274-285
Abstract
Medications used in the treatment of human immunodeficiency virus (HIV) often have drug-drug interactions which complicate treatment of psychiatric illnesses in HIV-infected patients. Protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) are the two classes of HIV medications most likely to be involved with interactions, with the majority occurring via the cytochrome P450 (CYP450) system. These interactions can result in either increased or decreased exposure to psychotropic and antiretroviral medications, often requiring dosage adjustments and increased monitoring. This article reviews some of the major drug interactions with antiretroviral agents.Keywords
This publication has 61 references indexed in Scilit:
- Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate studyGeneral Hospital Psychiatry, 2009
- Co-occurrence of Treatment Nonadherence and Continued HIV Transmission Risk Behaviors: Implications for Positive Prevention InterventionsPsychosomatic Medicine, 2008
- Role of Depression, Stress, and Trauma in HIV Disease ProgressionPsychosomatic Medicine, 2008
- Does the Presence of a Current Psychiatric Disorder in AIDS Patients Affect the Initiation of Antiretroviral Treatment and Duration of Therapy?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Use of Psychotropic Medications Among HIV-Infected Patients in the United StatesAmerican Journal of Psychiatry, 2003
- Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Addressing the Challenges of AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Management of Psychiatric Disorders in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2001
- Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United StatesArchives of General Psychiatry, 2001
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996